Boosting betaine may be a treatment for schizophrenia
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
Jun 27
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
Jun 19
Gray matter volume links symptoms in autism
Low gray matter volume in the posterior superior parietal lobule (pSPL) was found to correlate with specific cognitive and perceptual symptoms of autism.
Jun 6
New mechanism allows lower energy requirement for OLED displays
Scientists have found a way to significantly reduce the amount of energy required by organic light emitting diodes (OLED) displays.
Jun 6
CAPON links Alzheimer’s plaques to neurodegeneration
CAPON was found to link Aβ plaques and hippocampal neurodegeneration in mice, explaining how these two hallmarks of Alzheimer’s disease are related.
May 20
AdR blockers protect the brain from stroke damage
Treatment with adrenergic receptor antagonists (AdR blockers) was able to reduce stroke-related brain damage in mice and improve motor recovery.
Apr 25
Trigger region found for epileptic absence seizures
A mouse model shows that absence seizures are triggered by faulty connections between the cortex and fast-spiking neurons in the striatum.
RIKEN at a Glance
30-day trend
- December 4, 2024
Albumin drops medicine off at cancer site then leaves the body - February 15, 2022
Green hydrogen production for fuel cells and fertilizers - December 27, 2015
Black smokers and electroecosystems - December 6, 2024
Scientists develop new and improved quantum gates - November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution
Topics
